Silo Pharma Shares Are Trading Higher After the Company Announced Intranasal Delivery of SPC-15 Showed a 'Rapid and Effective' Drug Exposure for PTSD Therapy.
Silo Pharma Shares Are Trading Higher After the Company Announced Intranasal Delivery of SPC-15 Showed a 'Rapid and Effective' Drug Exposure for PTSD Therapy.
Silo Pharma宣佈 SPC-15 的鼻內分娩顯示 “快速有效” 的創傷後應激障礙療法藥物敞口，此後，Silo Pharma的股價走高。
Silo Pharma Shares Are Trading Higher After the Company Announced Intranasal Delivery of SPC-15 Showed a 'Rapid and Effective' Drug Exposure for PTSD Therapy.
Silo Pharma宣佈 SPC-15 的鼻內分娩顯示 “快速有效” 的創傷後應激障礙療法藥物敞口，此後，Silo Pharma的股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。